Characteristics and outcomes of 727 patients with mycosis fungoides and Sezary syndrome from a Brazilian cohort

被引:10
作者
Miyashiro, Denis [1 ]
Sanches, Jose A. [1 ]
机构
[1] Univ Sao Paulo, Med Sch, Hosp Clin, Div Clin Dermatol, 255 Dr Eneas Carvalho Aguiar Ave,3rd Floor, Sao Paulo, Brazil
关键词
T-CELL LYMPHOMA; PROGNOSTIC-FACTORS; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; PERIPHERAL-BLOOD; SURVIVAL; RISK; CLASSIFICATION; DISEASE; RECOMMENDATIONS;
D O I
10.1111/ijd.15865
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Mycosis fungoides (MF) and Sezary syndrome (SS) are the most prevalent cutaneous lymphomas. They were not described in a large Brazilian cohort yet. We aimed, with this single-center, retrospective cohort analysis, to describe the characteristics and outcomes of MF/SS in a tertiary public health service in Brazil. Methods MF/SS patients evaluated at the University of Sao Paulo Medical School between 1989 and 2018 were included. Data were collected at diagnosis. Demographic, clinical, histopathological, immunopathological, molecular, laboratory, and follow-up data were analyzed. Results Among 727 patients, 92.6% (673) were diagnosed with MF, 7.4% (54) with SS. There were 51.2% (372) of males, 48.8% (355) of females. The median age was 51.8 years; it was higher in erythrodermic MF (60.2) and SS (60.9). Among MF, 41.8% (281) had classic MF, 4.9% (33) folliculotropic MF, 1.8% (12) granulomatous slack skin, and 0.3% (2) pagetoid reticulosis. Common subtypes included erythrodermic (14.1%, 95), hypopigmented (10.8%, 73), and poikilodermatous MF (10.8%, 73). Extracutaneous involvement was rare. Five, 10, 20, and 30-year overall survival rates were 97.3%, 92.4%, 82.6%, and 82.6% for early-stage, and 58.6%, 42.7%, 20.8%, and 15.4% for advanced-stage disease, respectively. After multivariate analysis, SS diagnosis, folliculotropic MF, erythrodermic MF, clinical stage, age (>= 60 years), increased lactate dehydrogenase, and large cell transformation conferred poorer prognosis. Conclusions We observed a higher percentage of hypopigmented MF compared to the literature, and demographic (older age) and prognostic (poorer prognosis) similarities between erythrodermic MF and SS, suggesting a possible relationship between these erythrodermic lymphomas. Factors associated with a poorer prognosis were compatible with the literature.
引用
收藏
页码:442 / 454
页数:13
相关论文
共 74 条
[31]   Health-related quality of life in patients with cutaneous T-cell lymphoma? [J].
Holahan, Heather M. ;
Farah, Ronda S. ;
Fitz, Sara ;
Mott, Sarah L. ;
Ferguson, Nkanyezi N. ;
McKillip, Julie ;
Link, Brian ;
Liu, Vincent .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (11) :1314-1319
[32]   Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients [J].
Jaque, Alejandra ;
Mereniuk, Alexandra ;
Walsh, Scott ;
Shear, Neil H. ;
Sade, Shachar ;
Zagorski, Brandon ;
Alhusayen, Raed .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (08) :933-939
[33]   Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers [J].
Jawed, Sarah I. ;
Myskowski, Patricia L. ;
Horwitz, Steven ;
Moskowitz, Alison ;
Querfeld, Christiane .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :205.e1-205.e16
[34]   Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part II. Prognosis, management, and future directions [J].
Jawed, Sarah I. ;
Myskowski, Patricia L. ;
Horwitz, Steven ;
Moskowitz, Alison ;
Querfeld, Christiane .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :223.e1-223.e17
[35]   A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas [J].
Kaito, Satoshi ;
Kanemasa, Yusuke ;
Sasaki, Yuki ;
Okuya, Toshihiro ;
Yamaguchi, Tsukasa ;
Funasaka, Chikako ;
Shimoyama, Tatsu ;
Omuro, Yasushi ;
Hishima, Tsunekazu ;
Maeda, Yoshiharu .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (04) :451-459
[36]   Immunopathogenesis and therapy of cutaneous T cell lymphoma [J].
Kim, EJ ;
Hess, S ;
Richardson, SK ;
Newton, S ;
Showe, LC ;
Benoit, BM ;
Ubriani, R ;
Vittorio, CC ;
Junkins-Hopkins, JM ;
Wysocka, M ;
Rook, AH .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :798-812
[37]   Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression [J].
Kim, YH ;
Liu, HL ;
Mraz-Gernhard, S ;
Varghese, A ;
Hoppe, RT .
ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :857-866
[38]   Sezary syndrome: A study of 176 patients at Mayo Clinic [J].
Kubica, Agnieszka W. ;
Davis, Mark D. P. ;
Weaver, Amy L. ;
Killian, Jill M. ;
Pittelkow, Mark R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) :1189-1199
[39]   Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sezary syndrome: a retrospective analysis of 174 patients [J].
Lebowitz, E. ;
Geller, S. ;
Flores, E. ;
Pulitzer, M. ;
Horwitz, S. ;
Moskowitz, A. ;
Kheterpal, M. ;
Myskowski, P. L. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (01) :108-114
[40]   Epidemiology and prognostic factors for mycosis fungoides and Sezary syndrome in a multi-ethnic Asian cohort: a 12-year review [J].
Lim, H. L. J. ;
Tan, E. S. T. ;
Tee, S. I. ;
Ho, Z. Y. ;
Boey, J. J. J. ;
Tan, W. P. ;
Tang, M. B. Y. ;
Shen, L. ;
Chan, Y. H. ;
Tan, S. H. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (08) :1513-1521